Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
JA Faraj, AJH Al-Athari, SED Mohie, IK Kadhim… - Medical Oncology, 2022 - Springer
The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination,
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
JA Faraj, AJH Al-Athari, SED Mohie… - Medical …, 2022 - search.proquest.com
The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination,
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies.
JA Faraj, AJH Al-Athari, SED Mohie… - Medical Oncology …, 2022 - europepmc.org
The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination,
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
Reprogramming the tumor microenvironment to improve the efficacy of cancer immunotherapies
JA Faraj, AJH Al-Athari, SED Mohie… - Medical oncology …, 2022 - pubmed.ncbi.nlm.nih.gov
The immunotherapeutic approaches based on checkpoint inhibitors, tumor vaccination,
immune cell-based therapy, and cytokines were developed to engage the patient's immune …
immune cell-based therapy, and cytokines were developed to engage the patient's immune …